Stock Events

Stock Events

Invesco NASDAQ Biotech UCITS 

€51.61
25
-€1.2-2.27% Tuesday 15:15

Statistics

Day High
52.54
Day Low
51.56
52W High
53.96
52W Low
33.78
Volume
2,417
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Expense Ratio

0.40%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SBIO.AS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap0
iShares NASDAQ Biotechnology ETF, directly competes by tracking a similar NASDAQ Biotech index, offering exposure to biotech and pharmaceutical companies.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, competes by providing exposure to the biotechnology sector of the S&P, which overlaps with the NASDAQ Biotech sector targeted by SBIO.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, competes by investing in companies involved in the development, production, and marketing of pharmaceuticals and biotechnology products.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, competes by tracking a different biotech index but targets a similar investment profile in the biotech industry.
Principal Healthcare Innovators
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF, competes by focusing on companies that are primarily involved in the research and development of healthcare innovations.
Virtus Biotech
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF, competes by investing in biotechnology companies with one or more drugs in Phase III clinical trials, similar to some constituents of SBIO.
Virtus Biotech Clinical Trials
BBC
Mkt Cap0
Virtus LifeSci Biotech Clinical Trials ETF, competes by focusing on companies in clinical trials, offering a more speculative investment similar to parts of the SBIO portfolio.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, competes by offering exposure to the biotech and genome industry, though with a dynamic selection process.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF, competes by focusing on the genomics industry, which is a subset of the broader biotech sector targeted by SBIO.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF, competes by investing in the genomic revolution, including CRISPR, gene editing, and therapeutics, overlapping with biotech innovations.

Holdings

Regions

Sectors

About

NA
Show more...
CEO
Country
NL
ISIN
IE00BQ70R696

Listings

MX
MX
SBION.MX
LSE
GB
SBIX.LSE
AS
NL
SBIO.AS
SW
CH
SBIO.SW

0 Comments

Share your thoughts

FAQ

What is Invesco NASDAQ Biotech UCITS stock price today?▼
The current price of SBIO.AS is €51.61 EUR — it has decreased by -2.27% in the past 24 hours. Watch Invesco NASDAQ Biotech UCITS stock price performance more closely on the chart.
What is Invesco NASDAQ Biotech UCITS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Invesco NASDAQ Biotech UCITS stocks are traded under the ticker SBIO.AS.
Is Invesco NASDAQ Biotech UCITS stock price growing?▼
SBIO.AS stock has fallen by -2.64% compared to the previous week, the month change is a -0.44% fall, over the last year Invesco NASDAQ Biotech UCITS has showed a +40.44% increase.
When did Invesco NASDAQ Biotech UCITS complete a stock split?▼
Invesco NASDAQ Biotech UCITS has not had any recent stock splits.